首页 | 本学科首页   官方微博 | 高级检索  
检索        

微小RNA与卵巢癌铂类耐药的研究进展
引用本文:程煜,鹿欣.微小RNA与卵巢癌铂类耐药的研究进展[J].国际肿瘤学杂志,2011,38(5):384-386.
作者姓名:程煜  鹿欣
作者单位:复旦大学附属妇产科医院,上海,200011
摘    要:微小RNA(micmRNA,miBNA)是广泛存在于生物体内的一类非编码的小RNA,miRNA是细胞增殖、死亡、应激抗性和脂肪代谢的关键调节因素,体外实验已经证实miRNA在卵巢癌耐药中起重要作用.卵巢癌铂类耐药的产生与发展是十分复杂的过程,研究结果显示,miRNA的表达对卵巢癌细胞株的铂类药物敏感性有着重要作用,能够...

关 键 词:微小RNA  卵巢肿瘤  抗药性  肿瘤

MicroRNA in platinum-resistance of ovarian cancer
CHENG Yu,LU Xin.MicroRNA in platinum-resistance of ovarian cancer[J].Journal of International Oncology,2011,38(5):384-386.
Authors:CHENG Yu  LU Xin
Abstract:MircoRNAs (miRNAs) are widely existing inorganisms, non-coding small RNA. MircoR-NAs play important role in cell proliferation, apoptosis, stress resistance and fat metabolism. In vitro studies indicate that miRNAs are important factors in platinum resistance of ovarian cancer cell lines. However, the pathway of platinum resistance of ovarian cancers is complex. Studies find miRNA expression play important roles in the sensitivity of platinum resistance of ovarian cancer cell lines , and can be used as an early alert for platinum resistance. Changing the expression of miRNA even can reverse the platinum resistance . But the regular role of miRNAs in target genes network is still unconfirmed. Thus, more studies about miRNA in vivo and animal tumor models are needed to identify the function of miRNAs in platinum resistance of ovarian cancer.
Keywords:MicroRNAs  Ovarian neoplasmas  Drug resistance  neoplasm
本文献已被 万方数据 等数据库收录!
点击此处可从《国际肿瘤学杂志》浏览原始摘要信息
点击此处可从《国际肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号